RxDoctor Payments Data

Amy Barker

Psychiatry · Omaha, NENPI 1861604209

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 197 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Lundbeck LLC at 31.5% of the total. Reporting peaked in 2019 at $1,623 and has fallen 89.1% since, to $177 in 2025.

$2,103in general payments, 2019–2025

Across 197 payments — averaging $10.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$663
  • AbbVie$540
  • Otsuka America Pharmaceutical, Inc.$332
  • Johnson & Johnson$170
  • Takeda Pharmaceuticals U.S.A., Inc.$87
  • Sunovion Pharmaceuticals Inc.$52
  • plus $260 from 10 others

What the payments were for

  • Food & beverage$2,103100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,103 in reported general payments places this provider in the 80th percentile of 160 psychiatry providers in Nebraska.

See all psychiatry providers in Nebraska

Other psychiatry in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →